Where does Amin Bio rank among its competitors?

Amin Bio ranks 1333rd amongst 1415 active competitors, of which 27 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Prescient Healthcare Group, which secured $18.3K in Jun, 2024.

Who are the top competitors of Amin Bio?

Amin Bio's top competitors include Clinigen, CMIC HOLDINGS and IntegriChain. Among them, Prescient Healthcare Group secured the most recent funding round in June, 2024.

Amin Bio - 2026 Company Profile & Competitors

Company Details

Provider of management and strategy consulting for pharmaceutical biotechnology industries. Services include project management, process and product development, due diligence, and market analysis. Technical offerings encompass quality and regulatory compliance, facility design and validation, manufacturing operations, and supply chain management. The firm assists with automation and recruitment needs within the biotechnology sector.

Website: aminbioconsulting.com
Email ID: *****@aminbioconsulting.com
Phone Number: +1 **********

Key Metrics

Stage

Unfunded

Ranked

1333^rd among 1415 active competitors

Similar Companies

Clinigen & 1674 more

View Amin Bio's full profile

Amin Bio has not raised any funding rounds yet.

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Amin Bio include Clinigen, CMIC HOLDINGS and IntegriChain. Here is the list of Top 10 competitors of Amin Bio, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Clinigen 2010, Burton-on-trent (United Kingdom), Acquired	Services in clinical trials & medicine supply	-	RBS Group, Santander Bank & 3 others	59/100
2nd	CMIC HOLDINGS 1985, Tokyo (Japan), Acquired	Contract service provider for biopharma companies	-	-	58/100
3rd	IntegriChain 2005, Philadelphia (United States), Acquired	Pharma commercialization solutions: data, consulting, and technology for market access	$2M	Activate Venture Partners, SaaS Capital & 4 others	58/100
4th	Fishawack 2001, Brighton (United Kingdom), Acquired	Provider of fully-integrated, cross-border services to global pharmaceutical organisations	$23.6M	-	57/100
5th	Prescient Healthcare Group 2007, London (United Kingdom), Series B	Consulting services for product strategy and decision support	$12.7M	Baird Capital, Intertrust & 8 others	56/100
6th	Fabtech 2002, Mumbai (India), Public	Provider of instruments for biotech, pharmaceutical, and biomedical industries	$175K	Acaciaa International TR LLC, T Square Enterprises ... & 9 others	56/100
7th	Diaceutics 2005, Belfast (United Kingdom), Public	Analytics based integrator for precision medicine	-	Herald Investment Management, SVB & 4 others	55/100
8th	Science Group 1986, Cambridge (United Kingdom), Public	Provider of product development, regulatory, and advisory services alongside the design and manufacture of systems for the defence and audio sectors	-	Herald Investment Management	49/100
9th	Sequence 2002, Morrisville (United States), Acquired	Consulting services provider	-	-	49/100
10th	Oxford PharmaGenesis 1998, Oxford (United Kingdom), Acquired	Provider of medical affairs, marketing, communication, consultancy, and other services for healthcare sector	-	-	48/100
1333rd	Amin Bio Unfunded	Provider of management and strategy consulting for pharmaceutical biotechnology industries	-	-	16/100